Fundz

VintaBio Names Jennifer Kingsley Chief Commercial Officer

PRIVATEAug 16, 2023

Position

Chief Commercial Officer

Company

VintaBio

Jennifer Kingsley
jennifer.kingsley@vintabio.com
PhiladelphiaManufacturingBiotechnologyTherapeutics

Description

VintaBio, a life sciences company with unmatched industry expertise in helping alleviate the viral vector bottleneck in cell and gene therapy development, named Jennifer Kingsley as its first Chief Commercial Officer to develop and implement the company's commercial strategy. With 25 years of life science commercial experience, including the past decade at Cytiva, Kingsley is poised to lead VintaBio through rapid growth following its unveiling as a premier CGT contract development and manufacturing organization earlier this year. VintaBio also hired Ann Lee as Chief of Staff. Ann has more than a decade of experience helping found and grow life sciences companies, most recently as Chief of Staff and VP Strategic Affairs for medtech company Zuko, Inc.

Quick answer

VintaBio Names Jennifer Kingsley Chief Commercial Officer (August 16, 2023). VintaBio is based in Philadelphia, Pennsylvania, United States.

Who is the new Chief Commercial Officer at VintaBio?
VintaBio named Jennifer Kingsley Chief Commercial Officer, announced August 16, 2023.
What did VintaBio announce on August 16, 2023?
VintaBio, a life sciences company with unmatched industry expertise in helping alleviate the viral vector bottleneck in cell and gene therapy development, named Jennifer Kingsley as its first Chief Commercial Officer to develop and implement the company's commercial strategy. With 25 years of life science commercial experience, including the past decade at Cytiva, Kingsley is poised to lead VintaBio through rapid...
What does VintaBio do?
VintaBio’s development and manufacturing team has over a century of experience in the cell and gene therapy space and its members have played key roles in the development of the most advanced therapies on the market...
Where is VintaBio based?
VintaBio is based in Philadelphia, Pennsylvania, United States.
Which similar companies made leadership changes around the same time?
AbSci Corp (August 14, 2023), Virax Biolabs (September 1, 2023), AnHeart Therapeutics (September 28, 2023) and HALO Precision Diagnostics (August 16, 2023) also announced leadership changes within 45 days of VintaBio.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at VintaBio, and when

A new leader at VintaBio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day VintaBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VintaBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VintaBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VintaBio

Location

Philadelphia, Pennsylvania, United States

About

VintaBio’s development and manufacturing team has over a century of experience in the cell and gene therapy space and its members have played key roles in the development of the most advanced therapies on the market today. Located in the historic Navy Yards of Philadelphia – the epicenter of cell and gene therapy innovation – VintaBio specializes in developing and manufacturing consistent, high-quality viral vectors, a vital and currently underserved area of CGT development. The company was founded by Junwei Sun and Dr. Shangzhen Zhou, who led development of the AAV vectors behind the first two FDA-approved gene therapies, as well as the lentiviral vector for the first FDA-approved cell therapy. VintaBio has raised $64 million in venture funding, which has been used to develop a brand new 22,500 square foot facility in Philadelphia created specifically to facilitate efficient cell and gene therapy manufacturing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VintaBio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jennifer
Likely contact at this company
••••••••@••••••••

See Jennifer's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for VintaBio's next move

Learn about Strategic plan

VintaBio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.